Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products

By LabMedica International staff writers
Posted on 12 Nov 2024

Tianlong Science and Technology (Shaanxi, China) is participating in the MEDICA 2024 exhibition where the company is showcasing its cutting-edge diagnostic solutions and latest products in biochemistry, immunology, POCT, and molecular diagnostics. More...

Among Tianlong’s innovations featuring at this year’s MEDICA is the Panall 8000 All-in-one Molecular Diagnosis system (Open system) that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Panall 8000 allows labs to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Also featuring at MEDICA 2024 is the Gentier X3 Series Real-Time PCR System that features three independent thermal blocks, supporting users to run a maximum 3×32 well samples in three different protocols simultaneously. This can help labs save a lot of time and budget. With the powerful and efficient temperature control system, user-friendly operational designs, Tianlong Gentier X3 Series can provide maximal reliability and efficiency for all real-time PCR needs. Tianlong is also highlighting the Biolum Portable ATP Hygiene Monitoring System Pro which features an innovative design, making it a smartphone in the user’s hand. Featuring state-of-the-art technology, the new device can provide rapid and accurate data to support hygiene monitoring programs. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever.

Additionally, Tianlong is presenting the V150 automatic chemiluminescence immunoassay analyzer designed for small and medium-sized laboratories, while also offering the capability for emergency testing in large hospitals and third-party laboratories. Alongside, Tianlong is highlighting the ZY-260 automatic clinical chemistry analyzer that uses concave grating photometry post-spectroscopic technology and has a constant speed of 200 tests/hour. The ZY-260 also features an AAA-supported system with improved traceability for ensuring the accuracy of results and has a high-capacity sample tray and reagent tray, allowing 72 clinical chemistry items to be run simultaneously.

Related Links:
Tianlong Science and Technology


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.